Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 57

Sort by

Sort Order Select

Journal Articles

Sensitive Monitoring of BCR-ABL1 Kinase Domain Mutations By Next Generation Sequencing for Optimizing Clinical Decisions in Philadelphia-Positive Acute Lymphoblastic Leukemia in the Graaph-2014 Trial

Blood (2019) 134 (Supplement_1): 1295.

https://doi.org/10.1182/blood-2019-124029

Published: 2019

Journal Articles

BCR-ABL1 p190 in CML: A Minor Breakpoint with a Major Impact

Shady Adnan Awad, MD, Helena Hohtari, MD, Komal Kumar Javarappa, PhD, Tania Brandstoetter, Daehong Kim, Swapnil Potdar, MSc, Caroline A Heckman, PhD, Soili Kytölä, PhD, Kimmo Porkka, Eszter Doma, PhD, Veronika Sexl, MD PhD, Matti Kankainen, PhD, Satu Mustjoki, MD PhD

Blood (2019) 134 (Supplement_1): 190.

https://doi.org/10.1182/blood-2019-126584

Published: 2019

Journal Articles

Health Insurance Status Impacts Rates of Overall Survival in Philadelphia-Positive Acute Lymphoblastic Leukemia

Jeremy Chang, MD, Sherry Zhang, MD, Mojtaba Akhtari, MD

Blood (2019) 134 (Supplement_1): 2581.

https://doi.org/10.1182/blood-2019-123738

Published: 2019

Journal Articles

Importance of Detection of Intracellular Myeloperoxidase, CD13, CD79a, CD22, CD3 and Terminal Deoxynucleotidyl Transferase By Flow Cytometry Diagnosis of Acute Leukemias

Aldair Sousa Paiva, PhD, Hugo Diogenes De Oliveira Paiva, MD, Geraldo Barroso Cavalcanti, Jr., PhD, Frank Bahia, MD, Rodrigo Villar Freitas, MD, Lenilton Silva Silveira, Jr., MD, Lorena KF Silva, Roberto C Vasconcelos, MD, Dany GKC Silva, Victor lima Soares, Erica Aires Gil, MD, Geisa Januario, Maria Fernandes, PhD, Alessandra Suelen Jardim

Blood (2018) 132 (Supplement 1): 5194.

https://doi.org/10.1182/blood-2018-99-118880

Published: 2018

Journal Articles

Efficacy of Dasatinib to Treat Molecular Relapse in an Adolescent with Philadelphia-Positive Acute Lymphoblastic Leukemia

Fara Petruzziello, MD, Giovanna Giagnuolo, MD, Giuseppe Menna, MD, Giovanni Cazzaniga, PhD, Giada Muccioli Casadei, PhD, Salvatore Buffardi, MD, Giovanna Maisto, Rosanna Parasole, MD

Blood (2017) 130 (Supplement 1): 5045.

https://doi.org/10.1182/blood.V130.Suppl_1.5045.5045

Published: 2017

Journal Articles

The Use of Anti-Thymocyte Globulin Is Associated with Decreased Risk of Chronic Graft-Versus-Host Disease without Impact on Survival after Allogeneic Peripheral Blood Stem Cell Transplantation for Adults with Philadelphia-Positive Acute Lymphoblastic Leukemia: An Analysis By the Acute Leukemia Working Party of the EBMT

Blood (2017) 130 (Supplement 1): 1971.

https://doi.org/10.1182/blood.V130.Suppl_1.1971.1971

Published: 2017

Journal Articles

Comparable Results of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia in First Complete Molecular Remission: An Analysis By the Acute Leukemia Working Party of the EBMT

Sebastian Giebel, Myriam Labopin, MD, Michael Potter, Xavier Poiré, MD, Henrik Sengeloev, MD, Gerard Socié, MD PhD, Anne Huynh, MD, Boris V Afanasyev, Professor, Urs Schanz, MD, Olle Ringden, Peter Kalhs, MD, Dietrich W. Beelen, Prof. Dr. MD, Antonio M. Campos, MD, Tamás Masszi, MD PhD, Mohamad Mohty, MD PhD, Arnon Nagler*, MD

Blood (2016) 128 (22): 512.

https://doi.org/10.1182/blood.V128.22.512.512

Published: 2016

Journal Articles

Comparative Analysis of Tyrosine Kinase Inhibitors-Related Pulmonary Hypertension in the Patients Treated By Imatinib, Dasatinib and Nilotinib

Mariko Minami, MD, Toshihiro Miyamoto, MD PhD, Takeshi Arita, MD PhD, Tomohiko Kamimura, MD PhD, Junichiro Yuda, MD, Yoshikane Kikushige, MD PhD, Yasuo Mori, MDPhD, Goichi Yoshimoto, MD PhD, Kenjiro Kamezaki, MD PhD, Koji Kato, MD PhD, Motoaki Shiratsuchi, MDPhD, Katsuto Takenaka, MD PhD, Hiromi Iwasaki, MDPhD, Satoshi Yamasaki, MD PhD, Tsuyoshi Muta, MD PhD, Kazuki Tanimoto, MD PhD, Ryosuke Ogawa, MD PhD, Tetsuya Eto, MD PhD, Koichi Akashi, MD PhD

Blood (2015) 126 (23): 1583.

https://doi.org/10.1182/blood.V126.23.1583.1583

Published: 2015

Journal Articles

Nilotinib Combined with Multi-Agents Chemotherapy for Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of a Prospective Study from a Single Center

Bingcheng Liu, MD, Ying Wang, MD, Chunlin Zhou, MDPhD, Hui Wei, MDPhD, Dong Lin, MDPhD, Wei Li, MD, Kaiqi Liu, Guangji Zhang, Shuning Wei, Yan Li, MD, Benfa Gong, Yuntao Liu, Yingchang Mi, MD PhD, Jianxiang Wang, MD

Blood (2015) 126 (23): 1301.

https://doi.org/10.1182/blood.V126.23.1301.1301

Published: 2015

Journal Articles

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Blood (2015) 126 (6): 746–756.

https://doi.org/10.1182/blood-2015-03-636548

Published: 2015

Includes: Supplemental data

Journal Articles

Backtracking BCR-ABL1 Mutants in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Relapsing on Tyrosine Kinase Inhibitors with Deep Sequencing: Implications for Routine Mutation Testing

Simona Soverini, PhD, Caterina De Benedittis, Cristina Papayannidis, MD, Luca Zazzeroni, Claudia Venturi, PhD, Ilaria Iacobucci, PhD, Domenico Russo, MD PhD, Paola Bresciani, Mario Luppi, Michele Baccarani, MD, Michele Cavo, MD, Giovanni Martinelli, MD

Blood (2014) 124 (21): 2259.

https://doi.org/10.1182/blood.V124.21.2259.2259

Published: 2014

Journal Articles

Quantification of the Minimal Residual Disease in Pediatric Philadelphia-Positive Acute Lymphoblastic Leukemia

Cristian Ferri, MSc, Cecilia Riccheri, MD, Julieta Bietti, MD, Alejandra Cedola, MD, Michele Bianchini, PhD, Luis Alberto Aversa, MD, Sandra Pennesi, MSc, Carolina Belli, PhD, Gustavo Milone, MD, Irene B Larripa, PhD

Blood (2014) 124 (21): 5344.

https://doi.org/10.1182/blood.V124.21.5344.5344

Published: 2014

Journal Articles

Dasatinib Drug Use Results Surveys For All Cases As Nationwide Real World Data

Yasuhito Nannya, MD, PhD, Kiyohiko Hatake, M.D., PhD, Mineo Kurokawa, MD, PhD, Mihoko Nishizawa, Jumpei Tetsuka, Machida Meiji, Tamada Hiroshi

Blood (2013) 122 (21): 1502.

https://doi.org/10.1182/blood.V122.21.1502.1502

Published: 2013

Journal Articles

Long-Term Results Of Allogeneic Stem Cell Transplantation In 56 Adult Patients With Philadelphia-Positive Acute Lymphoblastic Leukemia: A 20-Year Single Center Experience

Adalberto Ibatici, MD, Fabio Guolo, MD, Federica Galaverna, Clara Delle Piane, MD, Alida Dominietto, Anna Maria Raiola, Maria Teresa van Lint, MD, Carmen Di Grazia, MD, Angelo Michele Carella, Andrea Bacigalupo, MD

Blood (2013) 122 (21): 5521.

https://doi.org/10.1182/blood.V122.21.5521.5521

Published: 2013

Journal Articles

Patients With Philadelphia-Positive Leukemia With BCR-ABL Kinase Mutations Prior To Allogeneic Transplantation Predominantly Relapse With The Same Mutation

Daniel N. Egan, MD, Lan Beppu, Jerald Radich, MD

Blood (2013) 122 (21): 4043.

https://doi.org/10.1182/blood.V122.21.4043.4043

Published: 2013

Journal Articles

Investigation Of p210 Bcr-Abl Rhogef Activity In The Progression Of Chronic Myelogenous Leukemia

Bryan T Ciccarelli, MA, Ilona Tala, PhD, Tinghui Hu, PhD, Dan Li, BS, Ru Chen, PhD, Qing Chen, PhD, Ian P Whitehead, PhD

Blood (2013) 122 (21): 3802.

https://doi.org/10.1182/blood.V122.21.3802.3802

Published: 2013

Journal Articles

Outcomes Of Tyrosine Kinase Inhibitors In Combination With Various Treatments Regimens In Adult Patients With Philadelphia Chromosome Positive Acute Lymphocytic Leukemia

Andrew Lin, PharmD, BCOP, Qin Zhou, Sean Devlin, PhD, Nelly G. Adel, PharmD, BCOP, BCPS, Dan Douer, MD

Blood (2013) 122 (21): 2644.

https://doi.org/10.1182/blood.V122.21.2644.2644

Published: 2013

Journal Articles

Nilotinib Combined With Multi-Agent Chemotherapy For Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Final Results Of Prospective Multicenter Phase 2 Study

Blood (2013) 122 (21): 55.

https://doi.org/10.1182/blood.V122.21.55.55

Published: 2013

Journal Articles

Hematopoietic Stem Cell Transplantation Combined with Imatinib to Treat Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia: A Comparative Research

Jia Chen, Feng Chen, Wu Depei

Blood (2012) 120 (21): 4555.

https://doi.org/10.1182/blood.V120.21.4555.4555

Published: 2012

Journal Articles

Imatinib (IM) and Interferon-Alpha (IFN-a) Maintenance Therapy Is Associated with Long-Term DFS in a Subset of Elderly Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Heike Pfeifer, MD, Sylvia Wystub, PhD, A. Binckebanck, Barbara Wassmann, Andreas Käbisch, Michael Lübbert, MD, Lothar Leimer, MD, Aristoteles Giagounidis, MD, Winfried Gassmann, MD, PhD, Patrick Brueck, MD, Hubert Serve, Prof. Dr. med., Dieter Hoelzer, MD, Oliver G. Ottmann, MD

Blood (2012) 120 (21): 1503.

https://doi.org/10.1182/blood.V120.21.1503.1503

Published: 2012

NARROW

Sensitive Monitoring of BCR-ABL1 Kinase Domain Mutations By Next Generation Sequencing for Optimizing Clinical Decisions in Philadelphia-Positive Acute Lymphoblastic Leukemia in the Graaph-2014 Trial

BCR-ABL1 p190 in CML: A Minor Breakpoint with a Major Impact

Health Insurance Status Impacts Rates of Overall Survival in Philadelphia-Positive Acute Lymphoblastic Leukemia

Importance of Detection of Intracellular Myeloperoxidase, CD13, CD79a, CD22, CD3 and Terminal Deoxynucleotidyl Transferase By Flow Cytometry Diagnosis of Acute Leukemias

Efficacy of Dasatinib to Treat Molecular Relapse in an Adolescent with Philadelphia-Positive Acute Lymphoblastic Leukemia

Comparable Results of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia in First Complete Molecular Remission: An Analysis By the Acute Leukemia Working Party of the EBMT

Comparative Analysis of Tyrosine Kinase Inhibitors-Related Pulmonary Hypertension in the Patients Treated By Imatinib, Dasatinib and Nilotinib

Nilotinib Combined with Multi-Agents Chemotherapy for Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of a Prospective Study from a Single Center

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Backtracking BCR-ABL1 Mutants in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Relapsing on Tyrosine Kinase Inhibitors with Deep Sequencing: Implications for Routine Mutation Testing

Quantification of the Minimal Residual Disease in Pediatric Philadelphia-Positive Acute Lymphoblastic Leukemia

Dasatinib Drug Use Results Surveys For All Cases As Nationwide Real World Data

Long-Term Results Of Allogeneic Stem Cell Transplantation In 56 Adult Patients With Philadelphia-Positive Acute Lymphoblastic Leukemia: A 20-Year Single Center Experience

Patients With Philadelphia-Positive Leukemia With BCR-ABL Kinase Mutations Prior To Allogeneic Transplantation Predominantly Relapse With The Same Mutation

Investigation Of p210 Bcr-Abl Rhogef Activity In The Progression Of Chronic Myelogenous Leukemia

Outcomes Of Tyrosine Kinase Inhibitors In Combination With Various Treatments Regimens In Adult Patients With Philadelphia Chromosome Positive Acute Lymphocytic Leukemia

Nilotinib Combined With Multi-Agent Chemotherapy For Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Final Results Of Prospective Multicenter Phase 2 Study

Hematopoietic Stem Cell Transplantation Combined with Imatinib to Treat Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia: A Comparative Research

Imatinib (IM) and Interferon-Alpha (IFN-a) Maintenance Therapy Is Associated with Long-Term DFS in a Subset of Elderly Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only